Tom Fremd - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Tom Fremd’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Hospitals,
- E-commerce,
- Cybersecurity,
- Messaging,
- Wellness,
- Women Founded,
- Enterprise Software,
- Lifestyle Products,
- Portfolio Management,
- Medical Technologies,
- Banking,
- Cloud Computing,
- Finance,
- Software,
- Manufacturing,
- Biotechnology,
- Healthcare IT,
- Medical Devices,
- Fashion,
- Cosmetics,
- Electronic Health Records (EHR),
- Legal Tech,
- FinTech,
- Natural Language Processing,
- B2C,
- Mergers and Acquisitions,
- Health Diagnostics,
- Digital Health,
- Medical,
- Information Technology,
- B2B,
- Health Tech,
- Pharmaceuticals,
- Healthcare Technology,
- Acquisitions
Social media:
Past investments:
- Novalar Pharmaceuticals
- StorageWay
- Colorescience
- Transcept Pharmaceuticals
- Internet Generation Storage
- NovoStent Corporation
- NovaCardia
- Avera Pharmaceutical
- PartnerGate
- Avantis Medical Systems
- Verus Pharmaceuticals
- SI-BONE
- Pulmonx
- Peninsula Pharmaceuticals
- Pivot Medical
- Somaxon Pharmaceuticals
- Epirus Biopharmaceuticals
- Cephren
- Marketwired
- GC Aesthetics
- Cerexa Inc.
- Sequel Pharmaceuticals
- Pure Life Renal
- MAKO Surgical
- moksha8 Pharmaceuticals
- SkinMedica
- Crown Laboratories
- Kareo
- Orexigen Therapeutics
- Tobira Therapeutics
- MINDBODY
- KFx Medical
- TigerConnect
- ARYx Therapeutics
- Bayhill Therapeutics
- Glaukos
- FinPay
- Asthmatx
- NeurogesX
Investor Profile
Tom Fremd is a Venture Capital, Private Equity Firm, Micro VC based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Novalar Pharmaceuticals, StorageWay, ColorescienceTranscept Pharmaceuticals, Internet Generation Storage, NovoStent Corporation, NovaCardia, Avera Pharmaceutical, PartnerGate, Avantis Medical Systems, Verus Pharmaceuticals, SI-BONE, Pulmonx, Peninsula Pharmaceuticals, Pivot Medical, Somaxon Pharmaceuticals, Epirus Biopharmaceuticals, Cephren, Marketwired, GC Aesthetics, Cerexa Inc., Sequel Pharmaceuticals, Pure Life Renal, MAKO Surgical, moksha8 Pharmaceuticals, SkinMedica, Crown Laboratories, Kareo, Orexigen Therapeutics, Tobira Therapeutics, MINDBODY, KFx Medical, TigerConnect, ARYx Therapeutics, Bayhill Therapeutics, Glaukos, FinPay, Asthmatx, NeurogesX, . Over time, Tom Fremd has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Tom Fremd is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, E-commerce, Cybersecurity, Messaging, Wellness, Women Founded, Enterprise Software, Lifestyle Products, Portfolio Management, Medical Technologies, Banking, Cloud Computing, Finance, Software, Manufacturing, Biotechnology, Healthcare IT, Medical Devices, Fashion, Cosmetics, Electronic Health Records (EHR), Legal Tech, FinTech, Natural Language Processing, B2C, Mergers and Acquisitions, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Health Tech, Pharmaceuticals, Healthcare Technology, Acquisitions may find it worthwhile to explore potential connections with Tom Fremd, as their portfolio suggests a familiarity and interest in this area.
Understanding Tom Fremd’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
